Profhilo Structra

Profhilo® Structura is a groundbreaking injectable treatment designed to lift, contour, and rejuvenate the facial profile by targeting superficial fat layers.

By regenerating and repositioning these fat layers, Profhilo® Structura counteracts the natural flattening of facial angles and tissue descent that occur over time. The result is a more lifted, naturally contoured profile without obvious projections or the appearance of artificial enhancements.

Profhilo® Structura is uniquely formulated to work harmoniously with superficial fat tissue. Its specific composition and concentration enhance this integration and compatibility.

It is developed using patented NAHYCO® technology, which stabilises a distinct complex of high and low- molecular-weight hyaluronic acid. This thermal process removes the need for the chemical cross-linkers that are commonly required in other hyaluronic acid formulations and fillers, ensuring a purer product.

Once injected, Profhilo® Structura activates ageing adipose fat cell receptors, subtly and safely encouraging them to mimic the behaviour of their youth.

Profhilo® Structura is clinically proven to restore superficial fat to its original position, effectively tackling age-related concerns like pronounced facial hollows, skin laxity, and the development of a squarer facial shape resulting from midface fat loss.

95% of patients noticed lasting enhancements in the mid-face area after the first treatment. This improvement was sustained three months later, highlighting the lasting benefits of Profhilo® Structura.

Profhilo® Structura is a natural and regenerative option for those desiring subtle enhancements without drastically altering their appearance. Beyond addressing age-related facial shifts, it can also restore lost facial fat due to rapid weight loss, including effects from using Ozempic.

A Profhilo® Structura treatment consists of two sessions, administered one month apart.

Profhilo® Structura is injected in the preauricular area – the upper cheek region – using a protocol that evaluates facial structure, including midface projection, hollows, laxity, and skin density.

There is minimal down-time with the treatment and patients can go about their day with ease after an appointment.

Profhilo® is injected into the dermis where it is clinically proven to provide tissue restoration without volumisation. It does this by waking up dormant fibroblast tissue to regenerate collagen and elastin, visibly improving the skin’s firmness, texture, and hydration.

Profhilo® Structura, on the other hand, is designed for deeper structural remodeling and is injected into the subcutaneous layers. It is clinically proven to reposition and regenerate the dynamic superficial fat pads located beneath the skin and connective tissue, and above the muscle and deep fat layers. Its advanced compatibility with fat cells helps counteract the flattening of facial angles and tissue descent that naturally occurs over time, resulting in a more lifted, contoured, and rejuvenated facial profile.

Both treatments offer unique benefits tailored to different skin concerns and treatment areas, ensuring a comprehensive approach to skin rejuvenation and anti-ageing.

Profhilo® Structura represents a unique category of advanced injectable treatments that specifically target and restore facial fat for natural, restorative and regenerative solution.

Unlike fillers that offer “mechanical” lifting and volumising effects, Profhilo® Structura adopts a restorative approach that the body recognises, controlling inflammation and providing subtle repositioning without triggering a ‘foreign body’ effect.

Unlike skin boosters, which are injected into the upper layers of the skin to enhance radiance with less concentrated hyaluronic acid, Profhilo® Structura specifically targets the midface superficial fat. This tissue layer requires a treatment that is both biocompatible and bioavailable with its unique cellular function and ageing process.

IBSA is a pharmaceutical multinational, inspired by the innovation of therapeutic solutions capable of improving the quality of life of patients, and shaped by a sense of responsibility that goes beyond drugs.

IBSA’s Ultrapure hyaluronic acid is characterized by a high degree of purity and quality, which is internationally recognized.

IBSA has developed new technologies like the NAHYCO® Hybrid Technology, which introduces a new world of hyaluronic acid represented by stable cooperative hybrid complexes. It is a new molecule of both high and low molecular weight stabilized through a thermal process, without any chemical agent.

IBSA Derma, the division of IBSA dedicated to aesthetics medicine, celebrates the uniqueness and authentic beauty of each individual, moving away from a world where beauty is standardized.

The NAHYCO® technology gave life to the PROFHILO® PRODUCT LINE, which includes injectables such as:

• PROFHILO® FOR FACE AND NECK
• PROFHILO® BODY
• PROFHILO® STRUCTURA (THE NOVELTY)

The aging process happens because various alterations take place in the bones, muscles, tissues, and skin of the face, all working together.

These changes take place in different areas of the face at varying times, onset at different ages for each person, and differ based on ethnic backgrounds.

The new frontier of lipolifting2 in response to aging. With high concentration hyaluronic acid, restores facial structure and leads to deep firmness.

The novelty within the PROFHILO® LINE that is specifically indicated for facial treatment and for the restoration of adipose tissue.4

AGING PROFILE 1
Key features include:

• Thinner skin and less density in tissues.
• Hollow in the cheeks
• Bones become more visible, especially around the temples and under the cheekbones.

AGING PROFILE 2
Key features include:

• Skin feels thicker and firmer overall.
• More volume tends to gather in lower areas.
• Skin and tissue lose support, causing increased sagging and drooping

PROFHILO® STRUCTURA offered a tailored approach based on your unique facial aging patterns. With two different protocols and techniques.